Hydroxyurea-induced leg ulceration in 14 patients

Patricia Best, Mazen S. Daoud, Mark R. Pittelkow, Robert M. Petitt

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Background: Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions. Objective: To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg. Design: Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy. Setting: A tertiary care medical center. Patients: Patients with myeloproliferative disorders who were treated with hydroxyurea. Results: 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64% of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted. Conclusion: Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.

Original languageEnglish (US)
Pages (from-to)29-32
Number of pages4
JournalAnnals of Internal Medicine
Volume128
Issue number1
DOIs
StatePublished - Jan 1 1998

Fingerprint

Hydroxyurea
Leg
Ulcer
Leg Ulcer
Myeloproliferative Disorders
Skin Ulcer
Therapeutics
Tertiary Care Centers
Antineoplastic Agents
Medical Records
Retrospective Studies

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hydroxyurea-induced leg ulceration in 14 patients. / Best, Patricia; Daoud, Mazen S.; Pittelkow, Mark R.; Petitt, Robert M.

In: Annals of Internal Medicine, Vol. 128, No. 1, 01.01.1998, p. 29-32.

Research output: Contribution to journalArticle

Best, Patricia ; Daoud, Mazen S. ; Pittelkow, Mark R. ; Petitt, Robert M. / Hydroxyurea-induced leg ulceration in 14 patients. In: Annals of Internal Medicine. 1998 ; Vol. 128, No. 1. pp. 29-32.
@article{6bbcc2f65b534821ac0940a75e83c344,
title = "Hydroxyurea-induced leg ulceration in 14 patients",
abstract = "Background: Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions. Objective: To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg. Design: Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy. Setting: A tertiary care medical center. Patients: Patients with myeloproliferative disorders who were treated with hydroxyurea. Results: 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64{\%} of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted. Conclusion: Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.",
author = "Patricia Best and Daoud, {Mazen S.} and Pittelkow, {Mark R.} and Petitt, {Robert M.}",
year = "1998",
month = "1",
day = "1",
doi = "10.7326/0003-4819-128-1-199801010-00005",
language = "English (US)",
volume = "128",
pages = "29--32",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "1",

}

TY - JOUR

T1 - Hydroxyurea-induced leg ulceration in 14 patients

AU - Best, Patricia

AU - Daoud, Mazen S.

AU - Pittelkow, Mark R.

AU - Petitt, Robert M.

PY - 1998/1/1

Y1 - 1998/1/1

N2 - Background: Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions. Objective: To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg. Design: Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy. Setting: A tertiary care medical center. Patients: Patients with myeloproliferative disorders who were treated with hydroxyurea. Results: 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64% of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted. Conclusion: Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.

AB - Background: Hydroxyurea is an antineoplastic agent commonly used to treat myeloproliferative disorders and other nonneoplastic conditions. Objective: To further define the typical features of hydroxyurea-related cutaneous ulcers of the leg. Design: Retrospective, descriptive study of the medical records of patients who developed leg ulcers while receiving hydroxyurea therapy. Setting: A tertiary care medical center. Patients: Patients with myeloproliferative disorders who were treated with hydroxyurea. Results: 14 patients with extremely painful leg ulcers were identified. The most common ulcer site was the malleoli. Multiple ulcers were seen in 64% of patients. Patients had received hydroxyurea for an average of 6 years before ulcers developed. All ulcers healed after discontinuation of hydroxyurea treatment, and 2 patients developed ulcers after treatment was restarted. Conclusion: Hydroxyurea induces painful leg ulcers that are usually difficult to treat and require cessation of hydroxyurea therapy.

UR - http://www.scopus.com/inward/record.url?scp=0031974586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031974586&partnerID=8YFLogxK

U2 - 10.7326/0003-4819-128-1-199801010-00005

DO - 10.7326/0003-4819-128-1-199801010-00005

M3 - Article

C2 - 9424978

AN - SCOPUS:0031974586

VL - 128

SP - 29

EP - 32

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 1

ER -